Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 22
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, coated | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| madrigal pharmaceuticals, inc. | 3 |
Exclusivity
Patents and exclusivities
22| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7452882 | REZDIFFRAresmetirom | substance, product | Sept 2027 |
| 10376517 | REZDIFFRAresmetirom | use | Sept 2033 |
| 11564926 | REZDIFFRAresmetirom | substance, product | Sept 2033 |
| 11986481 | REZDIFFRAresmetirom | use | Sept 2033 |
| 9266861 | REZDIFFRAresmetirom | substance, product | Sept 2033 |
| 12661359 | REZDIFFRAresmetirom | use | Jan 2042 |
| 12377104 | REZDIFFRAresmetirom | use | Feb 2045 |
| 12667575 | REZDIFFRAresmetirom | use | Feb 2045 |
| Product | Exclusivity | Until |
|---|---|---|
| REZDIFFRARESMETIROM | NCE New chemical entity | Mar 2029 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| REZDIFFRA | Resmetirom | tablet, coated, oral | 82576-060NDA |
| REZDIFFRA | resmetirom | tablet, coated, oral | 82576-080NDA |
| REZDIFFRA | RESMETIROM | tablet, coated, oral | 82576-100NDA |
Compare
Other companies listing resmetirom
- Teva API India Private Ltd.2 sites · 36 NDC
Enquiry
Common questions
- Is Madrigal Pharmaceuticals, Inc. FDA approved?
- Madrigal Pharmaceuticals, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Madrigal Pharmaceuticals, Inc. make?
- 3 products are listed under Madrigal Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.